These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19151334)
21. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription. Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314 [TBL] [Abstract][Full Text] [Related]
22. Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. Tynan SH; Lundeen SG; Allan GF J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):225-39. PubMed ID: 15336700 [TBL] [Abstract][Full Text] [Related]
23. SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway. Böhm J; Sustmann C; Wilhelm C; Kohlhase J Biochem Biophys Res Commun; 2006 Sep; 348(3):898-907. PubMed ID: 16899215 [TBL] [Abstract][Full Text] [Related]
24. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10). McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873 [TBL] [Abstract][Full Text] [Related]
25. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator. Xing X; Du X; Lu Z; Ning T; Su X; Ke Y Gene; 2005 Jan; 344():161-9. PubMed ID: 15656982 [TBL] [Abstract][Full Text] [Related]
27. Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus. Feriotto G; Finotti A; Breveglieri G; Treves S; Zorzato F; Gambari R FEBS J; 2007 Sep; 274(17):4476-90. PubMed ID: 17681019 [TBL] [Abstract][Full Text] [Related]
28. New insights into the regulation of CYP2C9 gene expression: the role of the transcription factor GATA-4. Mwinyi J; Nekvindová J; Cavaco I; Hofmann Y; Pedersen RS; Landman E; Mkrtchian S; Ingelman-Sundberg M Drug Metab Dispos; 2010 Mar; 38(3):415-21. PubMed ID: 19995889 [TBL] [Abstract][Full Text] [Related]
29. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells. Linher-Melville K; Haftchenary S; Gunning P; Singh G Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132 [TBL] [Abstract][Full Text] [Related]
30. Leptin signaling regulates hypothalamic expression of nescient helix-loop-helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3). Al Rayyan N; Zhang J; Burnside AS; Good DJ Mol Cell Endocrinol; 2014 Mar; 384(1-2):134-42. PubMed ID: 24486192 [TBL] [Abstract][Full Text] [Related]
31. Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia. Li P; Grgurevic S; Liu Z; Harris D; Rozovski U; Calin GA; Keating MJ; Estrov Z PLoS One; 2013; 8(6):e64678. PubMed ID: 23750211 [TBL] [Abstract][Full Text] [Related]
32. STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancer. Armanious H; Gelebart P; Mackey J; Ma Y; Lai R Int J Clin Exp Pathol; 2010 Jul; 3(7):654-64. PubMed ID: 20830236 [TBL] [Abstract][Full Text] [Related]
33. Human Trefoil Factor 3 induces the transcription of its own promoter through STAT3. Sun Y; Wang L; Zhou Y; Mao X; Deng X Sci Rep; 2016 Jul; 6():30421. PubMed ID: 27453253 [TBL] [Abstract][Full Text] [Related]
34. Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer. Haviland R; Eschrich S; Bloom G; Ma Y; Minton S; Jove R; Cress WD PLoS One; 2011; 6(10):e24923. PubMed ID: 22046235 [TBL] [Abstract][Full Text] [Related]
35. Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis. Qayoom H; Bashir S; Khan R; Hussain MU; Wani S; Mir MA Comput Biol Chem; 2024 Oct; 112():108164. PubMed ID: 39098137 [TBL] [Abstract][Full Text] [Related]
36. [Signal transducer and activator of transcription 3 promotes vascular endothelial cell proliferation and migration by fractalkine]. Fan L; Li H; Zhang H; Li H; Huang F; Zhang Z; Dai Z; Xiang Y; Yao A; Li J; Liao X Sheng Wu Gong Cheng Xue Bao; 2019 Apr; 35(4):677-686. PubMed ID: 31001953 [TBL] [Abstract][Full Text] [Related]
37. Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. Itou J; Li W; Ito S; Tanaka S; Matsumoto Y; Sato F; Toi M J Biol Chem; 2018 Apr; 293(17):6556-6564. PubMed ID: 29511085 [TBL] [Abstract][Full Text] [Related]
38. STAT3 Partly Inhibits Cell Proliferation Xu H; Ma G; Mu F; Ning B; Li H; Wang N Front Genet; 2021; 12():678667. PubMed ID: 34239543 [TBL] [Abstract][Full Text] [Related]
39. Anomalous behaviour of the STAT3 binding site in the human c-myc P2 promoter. Vougier S; Cheung SH; Li L; Hodgson G; Shaw PE Biochem Biophys Res Commun; 2007 Dec; 364(3):627-32. PubMed ID: 17959148 [TBL] [Abstract][Full Text] [Related]
40. SALL4: an emerging cancer biomarker and target. Zhang X; Yuan X; Zhu W; Qian H; Xu W Cancer Lett; 2015 Feb; 357(1):55-62. PubMed ID: 25444934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]